ANALYST-UPGRADE filed
UBS double upgraded NVDA from Neutral to Buy with a new $225 PT, representing 21% upside from current levels. The move follows Wells Fargo and Piper Sandler upgrades in the past two weeks. Consensus remains mixed with only 40% Buy-rated (20/50), below average conviction. UBS’s accuracy is 50% (1/2), below peer median of 55%. Analyst momentum is positive: 3 upgrades in 30 days, 0 downgrades. EPS estimates are trending down over 30 days: -2 net revisions. Institutional activity shows divergence, FMR doubled down while Renaissance trimmed -58.6%. Earnings due in 7 days. Contrarian call from low-accuracy firm ahead of event limits conviction.